EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide

Ramakrishnan Venkatasubramanian, Passant M Al-Maghrabi, Oscar Alavi, Tania Lind, Philip Jonas Sassene, Jacob J K Kirkensgaard, Pablo Mota-Santiago, Thomas Rades, Anette Müllertz

Journal of Controlled Release · 2025-03 · 379 · 440-451

DOI: 10.1016/j.jconrel.2025.01.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-03. Verfasst von Ramakrishnan Venkatasubramanian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark. Electronic address: venkatasubramanian.ramakrishnan…. Hauptthemen laut MEDLINE: Peptides, Drug Delivery Systems, Venoms, Hypoglycemic Agents. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Phospholipid Research Center, VINNOVA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to predict the absorption of exenatide (Ex), a GLP-1 analogue, after oral dosing to rats in self-nanoemulsifying drug delivery systems (SNEDDS), using in vitro methods, was assessed. Ex was complexed with soybean phosphatidylcholine (SPC) prior to loading into SNEDDS. A design of experiments (DoE) approach was employed to develop SNEDDS incorporating medium-chain triglycerides (MCT), medium-chain mono- and diglycerides (MGDG), Kolliphor® RH40, and monoacyl phosphatidylcholine. SNEDDS with higher proportions of MGDG and Kolliphor® RH40 demonstrated a 9-fold reduction in droplet size (230 to 26 nm), a 1.5-fold decrease in lipolysis (0.23 to 0.34 mmol of FFA), and a 2-fold enhancement in exenatide protection against proteolysis (73 % to 38 %) compared to those with higher MCT content. Permeability studies in Caco-2 cells showed that SNEDDS with higher proportion of MGDG displayed a 40-fold increase in apparent permeability of FD4, when compared to SNEDDS with higher proportion of MCT. An oral gavage study in rats revealed a 1.8-fold higher absorption of Ex in SNEDDS with a higher proportion of MGDG and Kolliphor®RH40 compared to SNEDDS with higher MCT. These results establish a clear in vitro-in vivo correlation, demonstrating that the selected in vitro methods effectively differentiated formulations with high and low absorption of exenatide after oral dosing in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesDrug Delivery SystemsVenomsHypoglycemic AgentsExenatideAnimalsCaco-2 CellsAdministration, OralHumansEmulsionsMaleRats, Sprague-DawleyIntestinal AbsorptionRatsPhosphatidylcholinesTriglycerides

Stichwörter der Autor:innen

Design of experimentsExenatideIn vitro- in vivo correlationOral bioavailabilityOral peptide drug deliverySelf-nanoemulsifying drug delivery systems (SNEDDS)

Substanzen

ExenatideEmulsionsPeptidesVenomsHypoglycemic AgentsPhosphatidylcholinesTriglycerides

Autor:innen und Institutionen

  • Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark. Electronic address: venkatasubramanian.ramakrishnan@sund.ku.dk.
  • Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark. Electronic address: passant.almaghrabi@sund.ku.dk.
  • Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark. Electronic address: oscar@alavi.dk.
  • Bioneer A/S, Kogle Allé 2, Hørsholm 2970, Denmark. Electronic address: tkl@bioneer.dk.
  • Novo Nordisk A/S, Novo Nordisk Park 1, Maaloev 2760, Denmark. Electronic address: pjsa@novonordisk.com.
  • Department of Food Science, University of Copenhagen, Frederiksberg C 1958, Denmark; Niels Bohr Institute, University of Copenhagen, Universitetsparken 5, Copenhagen 2100, Denmark. Electronic address: jjkk@food.ku.dk.

Förderung

  • Vetenskapsrådet
  • Phospholipid Research Center
  • VINNOVA
  • Svenska Forskningsrådet Formas
  • Hartmann Foundation

Zitieren

APA

Venkatasubramanian, R., Al-Maghrabi, P. M., Alavi, O., Lind, T., Sassene, P. J., Kirkensgaard, J. J. K., Mota-Santiago, P., Rades, T., & Müllertz, A. (2025). Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide. Journal of Controlled Release, 379, 440-451. https://doi.org/10.1016/j.jconrel.2025.01.013

Vancouver

Venkatasubramanian R, Al-Maghrabi PM, Alavi O, Lind T, Sassene PJ, Kirkensgaard JJK, et al. Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide. Journal of Controlled Release. 2025;379:440-451. doi:10.1016/j.jconrel.2025.01.013

BibTeX
@article{Venkatasubramanian2025,
  author = {Venkatasubramanian, Ramakrishnan and Al-Maghrabi, Passant M and Alavi, Oscar and Lind, Tania and Sassene, Philip Jonas and Kirkensgaard, Jacob J K and Mota-Santiago, Pablo and Rades, Thomas and Müllertz, Anette},
  title = {Design, evaluation, and in vitro–in vivo correlation of self-nanoemulsifying drug delivery systems to improve the oral absorption of exenatide},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {379},
  pages = {440--451},
  doi = {10.1016/j.jconrel.2025.01.013}
}
Kostenlos starten →